1 ing intracerebroventricular (i.c.v.) administration of GALC we noted a significant, 16.5%, reduction in the GALC substrat

2                                                             We noted a significant, albeit modest, treatment effect in th

3                                                             We noted a significant and substantial decrease in skin cance

4                                                             We noted a significant but manageable mutation rate, possibly

5                 In a case-control study of archived plasma, we noted a significant correlation between miRNA levels and p

6                                                             We noted a significant decrease in UV-induced hypertrophy, su

7                                                In parallel, we noted a significant decrease of IL-17-producing CD3(+)CD4(

8                                        In these experiments we noted a significant effect of dCTP, an allosteric modifier

9                                                             We noted a significant effect of the year of diagnosis on the

10                             Even among these putative loci, we noted a significant enrichment for genes specifically expr

11 he benefit of statin therapy in the four randomised trials, we noted a significant gradient (p=0.0277) of increasing rela

12      In addition to the increased sensitivity of the assay, we noted a significant increase (approximately 40-fold) in th

13                                                             We noted a significant increase in development of rectal canc

14                              In the multivariable analysis, we noted a significant increase in positive attitudes in rela

15 th ovulatory and anovulatory women with polycystic ovaries, we noted a significant increase in the percentage of early gr

16     By contrast, in low-income and middle-income countries, we noted a significant increase of 22% (5-30) in incidence of

17                                                             We noted a significant interaction between treatment and prot

18                                               Additionally, we noted a significant inverse correlation between Corynebact

19 lity reduction was not significant in the primary analysis, we noted a significant mortality reduction with MMS when prev

20                                                             We noted a significant negative correlation between the abili

21                                                    However, we noted a significant net reduction in bodyweight (-0.66 kg

22                                                             We noted a significant p53-dependent increase in the levels o

23                                                             We noted a significant reduction in symptom and disability ou